Advanced search
1 file | 189.83 KB

Candidemia in critically ill patient: An analysis of daily antifungal therapy related costs

Author
Organization
Abstract
Data on the cost of antifungal therapy in critically ill. patients with candidemia are Lacking. Therefore, a historical observational cohort study was conducted to evaluate the daily cost of antifungal treatment in the critically ill with a microbiologically documented nosocomial candidemia. Over a four-year period (2003-2006), costs were calculated according to the causative pathogen, the source of infection and survivors versus non-survivors, respectively. Candidemia in critically ill patients represents a significant economic burden in terms of daily antimicrobial costs.

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 189.83 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Vandijck, Dominique, Stijn Blot, Sonia Labeau, Franky Buyle, Mieke DEPAEMELAERE, Koenraad Vandewoude, and Johan Decruyenaere. 2008. “Candidemia in Critically Ill Patient: An Analysis of Daily Antifungal Therapy Related Costs.” Journal De Mycologie Medicale 18 (2): 96–99.
APA
Vandijck, D., Blot, S., Labeau, S., Buyle, F., DEPAEMELAERE, M., Vandewoude, K., & Decruyenaere, J. (2008). Candidemia in critically ill patient: An analysis of daily antifungal therapy related costs. JOURNAL DE MYCOLOGIE MEDICALE, 18(2), 96–99.
Vancouver
1.
Vandijck D, Blot S, Labeau S, Buyle F, DEPAEMELAERE M, Vandewoude K, et al. Candidemia in critically ill patient: An analysis of daily antifungal therapy related costs. JOURNAL DE MYCOLOGIE MEDICALE. 2008;18(2):96–9.
MLA
Vandijck, Dominique, Stijn Blot, Sonia Labeau, et al. “Candidemia in Critically Ill Patient: An Analysis of Daily Antifungal Therapy Related Costs.” JOURNAL DE MYCOLOGIE MEDICALE 18.2 (2008): 96–99. Print.
@article{428351,
  abstract     = {Data on the cost of antifungal therapy in critically ill. patients with candidemia are Lacking. Therefore, a historical observational cohort study was conducted to evaluate the daily cost of antifungal treatment in the critically ill with a microbiologically documented nosocomial candidemia. Over a four-year period (2003-2006), costs were calculated according to the causative pathogen, the source of infection and survivors versus non-survivors, respectively. Candidemia in critically ill patients represents a significant economic burden in terms of daily antimicrobial costs.},
  author       = {Vandijck, Dominique and Blot, Stijn and Labeau, Sonia and Buyle, Franky and DEPAEMELAERE, Mieke and Vandewoude, Koenraad and Decruyenaere, Johan},
  issn         = {1156-5233},
  journal      = {JOURNAL DE MYCOLOGIE MEDICALE},
  language     = {eng},
  number       = {2},
  pages        = {96--99},
  title        = {Candidemia in critically ill patient: An analysis of daily antifungal therapy related costs},
  url          = {http://dx.doi.org/10.1016/j.mycmed.2008.04.006},
  volume       = {18},
  year         = {2008},
}

Altmetric
View in Altmetric
Web of Science
Times cited: